Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease

Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease

As a longstanding problem, Alzheimer’s disease (AD) has stymied researchers in the medical field with its increasing incidence and enormous treatment difficulty. Silymarin has always been valued by researchers for its good efficacy and safety in treating liver disease. Recent studies have...

Full description

Bibliographic Details
Main Authors:	Hong Guo, Hui Cao, Xiaowei Cui, Wenxiu Zheng, Shanshan Wang, Jiyang Yu, Zhi Chen
Format:	Article
Language:	English
Published:	MDPI AG 2019-05-01
Series:	Molecules
Subjects:	silymarin Alzheimer’s disease (AD) amyloid β-protein (Aβ) acetylcholine (ACh) oxidative stress neuroinflammatory
Online Access:	https://www.mdpi.com/1420-3049/24/9/1748

Similar Items

On the Inadequacy of the Current Transgenic Animal Models of Alzheimer’s Disease: The Path Forward
by: Vladimir Volloch, et al.
Published: (2024-03-01)

β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease
by: Nanbu Wang, et al.
Published: (2020-01-01)

DOENÇA DE ALZHEIMER: HIPÓTESES ETIOLÓGICAS E PERSPECTIVAS DE TRATAMENTO
by: Anna De Falco, et al.
Published: (2016-01-01)

Assessment of apigenin-7-glucoside and luteolin-7-glucoside as multi-targeted agents against Alzheimer's disease: a molecular docking study
by: Erman Salih Istifli, et al.
Published: (2021-08-01)

Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
by: Yixiu Zhou, et al.
Published: (2018-06-01)

Recent Advances in Research on Functional Ingredients in Tea that Can Prevent Alzheimer Disease
by: Jingyi TANG, et al.
Published: (2022-09-01)

Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer’s Disease
by: Md. Ataur Rahman, et al.
Published: (2020-12-01)

Effects of Subcortical Atrophy and Alzheimer’s Pathology on Cognition in Elderly Type 2 Diabetes: The Alzheimer’s Disease Neuroimaging Initiative Study
by: Wen Zhang, et al.
Published: (2022-01-01)

Curcumin Scaffold as a Multifunctional Tool for Alzheimer’s Disease Research
by: Haijun Yang, et al.
Published: (2022-06-01)

Interactions of AChE with Aβ Aggregates in Alzheimer’s Brain: Therapeutic Relevance of IDN 5706
by: Francisco Javier Carvajal, et al.
Published: (2011-09-01)

Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
by: Jihye Hwang, et al.
Published: (2021-09-01)

Neuroprotective Natural Products for Alzheimer’s Disease
by: Xin Chen, et al.
Published: (2021-05-01)

Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease
by: Qiu Han, et al.
Published: (2018-12-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
by: Kaden L. Nystuen, et al.
Published: (2024-01-01)

Recent Research Progress in Fluorescent Probes for Detection of Amyloid-β In Vivo
by: Zhen-Yu Zhang, et al.
Published: (2023-11-01)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
by: Anne-Cathrine S. Vogt, et al.
Published: (2023-02-01)

Synthesis and Preliminary Biological Evaluation of 18F Labeled Styryl Pyrimidine Derivatives as Aβ-Imaging Agents for Alzheimer’s Disease
by: LI Zhongyong;SHEN Langtao;QIAO Laicheng;WANG Chengzhi;LIANG Wei;SHEN Chen;CUI Haiping
Published: (2021-08-01)

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology
by: Fiona E. McAlpine, et al.
Published: (2009-04-01)

Effect of green tea extract EGCG on the improvement of Alzheimer’s and obesity mice
by: LIU Yang, et al.
Published: (2020-05-01)

Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer’s disease and the potential role of local estrogens
by: Yu-Ting Hu, et al.
Published: (2023-03-01)

The Effect of Oral Administration of Silymarin on Serum Levels of Tumor Necrosis Factor-α and Interleukin-1ß in Patients with Rheumatoid Arthritis
by: Mehrdad Shavandi, et al.
Published: (2022-12-01)

Erratum: Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer's disease and the potential role of local estrogens
by: Frontiers Production Office
Published: (2023-05-01)

Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer’s Continuum
by: Feng-Feng Pan, et al.
Published: (2022-03-01)

Development of p-Tau Differentiated Cell Model of Alzheimer’s Disease to Screen Novel Acetylcholinesterase Inhibitors
by: Giuseppe Uras, et al.
Published: (2022-11-01)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
by: Ziyi Luo, et al.
Published: (2021-07-01)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
by: Judite R. M. Coimbra, et al.
Published: (2018-05-01)

β-amyloid oligomers in aging and Alzheimer's disease
by: Kathleen R. Zahs, et al.
Published: (2013-07-01)

High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer’s Disease Patients but Not in Non-Alzheimer’s Disease Dementia
by: Giulia Bivona, et al.
Published: (2022-09-01)

Roles of Stem Cells in the Treatment of Alzheimer’s Disease
by: Yasaman Ebrahimikia, et al.
Published: (2020-06-01)

Mahanimbine Improved Aging-Related Memory Deficits in Mice through Enhanced Cholinergic Transmission and Suppressed Oxidative Stress, Amyloid Levels, and Neuroinflammation
by: Vasudevan Mani, et al.
Published: (2021-12-01)

Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents
by: Bo Li, et al.
Published: (2017-06-01)

H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
by: Luying Qiao, et al.
Published: (2023-03-01)

Conformational Essentials Responsible for Neurotoxicity of Aβ42 Aggregates Revealed by Antibodies against Oligomeric Aβ42
by: Chuli Song, et al.
Published: (2022-10-01)

Unique pharmacological property of ISRIB in inhibition of Aβ-induced neuronal cell death
by: Toru Hosoi, et al.
Published: (2016-08-01)

Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1
by: Courtney J. Mycroft-West, et al.
Published: (2021-04-01)

The Possible Neuroprotective Effect of Silymarin against Aluminum Chloride-Prompted Alzheimer’s-Like Disease in Rats
by: Hanaa R. Aboelwafa, et al.
Published: (2020-09-01)

Insulin promotes amyloid precursor protein metabolism in an Alzheimer's disease cell model
by: HU Rong, et al.
Published: (2020-06-01)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
by: Francesca Mantile, et al.
Published: (2020-11-01)

Tetrapeptide Ac-HAEE-NH<sub>2</sub> Protects α4β2 nAChR from Inhibition by Aβ
by: Evgeny P. Barykin, et al.
Published: (2020-08-01)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
by: Yuanxin Zhao, et al.
Published: (2022-07-01)